Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Sell · Filed 24/05/29

Trade details

Type: Insider sale
Amount: $715,205
Shares · price: 1,565 sh · $457.00 a share
Held after: 121,374 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Trade date: 24/05/24
Filed: 24/05/29
Days to filing: 5 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/24~24/06/23

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3M
5,995 sh
$3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27